Phase I clinical trial in patients with recurrent gliomas: delta-24-RGD oncolytic adenovirus induces an antiglioma immune-response

被引：0
|
作者：
Fueyo, J. [1 ]
Gomez-Manzano, C. [1 ]
Conrad, C. [1 ]
Heimberger, A. [1 ]
Vence, L. [1 ]
Aldape, K. [1 ]
Yung, W. A. [1 ]
Sawaya, R. [1 ]
Fuller, G. [1 ]
Lang, F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
    Page, John G.
    Tian, Baohong
    Schweikart, Karen
    Tomaszewski, Joseph
    Harris, Ray
    Broadt, Trevor
    Polley-Nelson, Judith
    Noker, Patricia E.
    Wang, Minghui
    Makhija, Sharmila
    Aurigemma, Rose
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04) : 389.e1 - 389.e10
  • [32] Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
    Matthews, Kellie
    Noker, Patricia E.
    Tian, Baohong
    Grimes, Sheila D.
    Fulton, Ronna
    Schweikart, Karen
    Harris, Raymond
    Aurigemma, Rose
    Wang, Minghui
    Barnes, Mack N.
    Siegal, Gene P.
    Hemminki, Akseli
    Zinn, Kurt
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4131 - 4137
  • [33] Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer -: Discussion
    Chambers, Setsuko K.
    Page
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04)
  • [34] Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
    Myers, Rae M.
    Harvey, Mary E.
    Greiner, Suzanne M.
    Soeffker, Diane C.
    Krempski, James W.
    Zollman, Paula J.
    Shelton, Steven E.
    Corey, Raffel
    Stephan, Goerss J.
    Timothy, Kaufmann J.
    Mark, Federspiel J.
    Kah-Whye, Peng
    Stephen, Russell J.
    Evanthia, Galanis
    [J]. MOLECULAR THERAPY, 2006, 13 : S113 - S113
  • [35] A phase I clinical trial with ONYX-015 (a selectively replicating adenovirus) administered by intratumoral injection in patients with recurrent head and neck carcinoma
    Kirn, D
    Ganley, I
    Nemunaitis, J
    Otto, R
    Soutar, D
    Kuhn, J
    Heise, C
    Propst, M
    Maack, C
    Eckhardt, G
    Kaye, S
    VonHoff, D
    [J]. CANCER GENE THERAPY, 1997, 4 (06) : O5 - O5
  • [36] Safety and dose-escalation study of a targeted oncolytic adenovirus, suratadenoturev (OBP-301), in patients with refractory advanced liver cancer: Phase I clinical trial
    Heo, Jeong
    Liang, Ja-Der
    Kim, Chang Won
    Woo, Hyun Young
    Shih, I-Lun
    Su, Tung-Hung
    Lin, Zhong-Zhe
    Chang, Stanley
    Urata, Yasuo
    Chen, Pei-Jer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [37] Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients
    Victora, G. D.
    Socorro-Silva, A.
    Volsi, E. C.
    Abdallah, K.
    Lima, F. D.
    Smith, R. B.
    Moyses, R. A.
    Zarate-Blades, C. R.
    Michaluart, P.
    Silva, C. L.
    Kalil, J.
    Coelho, V.
    [J]. CANCER GENE THERAPY, 2009, 16 (07) : 598 - 608
  • [38] Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients
    G D Victora
    A Socorro-Silva
    E C Volsi
    K Abdallah
    F D Lima
    R B Smith
    R A Moyses
    C R Zárate-Bladés
    P Michaluart
    C L Silva
    J Kalil
    V Coelho
    [J]. Cancer Gene Therapy, 2009, 16 : 598 - 608
  • [39] A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer
    Kim, K.
    Wang, M.
    Barnes, M.
    O'Malley, J.
    You, Z.
    Preuss, M.
    Siegal, G.
    Zinn, K.
    Curie, D.
    Alvarez, R.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S31 - S31
  • [40] Phase I clinical trial of peptide vaccine derived from HSP105 and analysis of immune response in vaccinated patients
    Shimizu, Yasuhiro
    Yoshikawa, Toshiaki
    Syoda, Kayoko
    Nosaka, Kazuto
    Shimomura, Manami
    Mizuno, Shoichi
    Wada, Satoshi
    Fujimoto, Yuki
    Kohashi, Kenichi
    Kojima, Takashi
    Endo, Itaru
    Nakatsura, Tetsuya
    [J]. CANCER SCIENCE, 2018, 109 : 1334 - 1334
12345